Published on in Vol 11, No 7 (2022): July
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/34206, first published
.
![Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes: Protocol for a Kidney End Points Real-world Study (COMBi-KID Study) Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes: Protocol for a Kidney End Points Real-world Study (COMBi-KID Study)](https://asset.jmir.pub/assets/d16c8b0469f70ce25c05e397d65150ca.png 480w,https://asset.jmir.pub/assets/d16c8b0469f70ce25c05e397d65150ca.png 960w,https://asset.jmir.pub/assets/d16c8b0469f70ce25c05e397d65150ca.png 1920w,https://asset.jmir.pub/assets/d16c8b0469f70ce25c05e397d65150ca.png 2500w)
Altmetric
Altmetric discovers Social Media mentions. Click the ‘See more details’ link for a full report.
Dimensions
Dimensions discovers Citations. Click the ‘details’ link for a full report.